| Iu Health Workplaces Services | |
|
Hse Health Care Center - Medcheck Suite 9669 E 146th St Nobles Ville IN 46060 | |
| (317) 621-2462 | |
| (317) 806-1692 |
| Full Name | Iu Health Workplaces Services |
|---|---|
| Speciality | Family Medicine |
| Location | Hse Health Care Center - Medcheck Suite, Nobles Ville, Indiana |
| Authorized Official Name and Position | Steve Zetzl (COMMUNITY EMPLOYER HEALTH) |
| Authorized Official Contact | 3176217598 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Iu Health Workplaces Services 1500 North Ritter Avenue Indianapolis IN 46219 Ph: (317) 497-6169 | Iu Health Workplaces Services Hse Health Care Center - Medcheck Suite 9669 E 146th St Nobles Ville IN 46060 Ph: (317) 621-2462 |
| NPI Number | 1205238771 |
|---|---|
| Provider Enumeration Date | 09/16/2014 |
| Last Update Date | 09/27/2018 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205238771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| 261Q00000X | Clinic/center | (* (Not Available)) | Secondary |
News Archive
A new polypill increases adherence to treatment following a myocardial infarction (MI), according to results from the FOCUS Study presented for the first time at ESC Congress 2014 today by principal investigator Dr Valentin Fuster, director of Mount Sinai Heart in New York, US.
EKF, announces it will highlight a new Stanbio Chemistry Glycated Albumin assay kit and its newly FDA cleared DiaSpect Tm hemoglobin point of care analyzer.
Percutaneous coronary intervention plus optimal medical therapy does not improve outcomes in patients with coronary artery disease, compared with optimal medical therapy alone, according to study results presented at the 56th Annual Scientific Session of the American College of Cardiology in New Orleans, and published online in the New England Journal of Medicine.
A review of previous studies indicates that the benefits of antidepressants for children and teens with depression or anxiety disorders may outweigh their risks, and that the increased risk for suicidal thoughts and attempts from using these medications is not statistically significant, according to an article in the April 18 issue of JAMA.
› Verified 7 days ago